Presentations

Keith Ward

Apr 23

Kuria announces presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024

- Kuria team to present potency, selectivity, and positive preclinical proof-of-concept data for lead NRF2 activator for both cornea and...

Keith Ward

Apr 5

Keith Ward

Feb 28

- Kuria's Chief Executive Officer Dr. Keith Ward to present company overview to premiere venture forum in the Southeast Kuria...

Keith Ward

Jan 3

Keith Ward

Dec 6, 2023

- Kuria's Chief Executive Officer and Chief Development Officer to share ophthalmic program updates and present corporate overview Kuria...

Keith Ward

Nov 10, 2023

- Chief Development Officer Dave Flory to present corporate overview and review Kuria's development plans for diseases of the cornea and...

Keith Ward

Oct 20, 2023

Keith Ward

Sep 20, 2023

Keith Ward

Aug 31, 2023